Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

KYG7487R1002
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00ZS40360
RGC
Regencell Bioscience Holdings
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Drug Manufacturers—Specialty & Generic · THEMEFOLIO: $HLTH
NAME
Regencell Bioscience Holdings
ISIN
KYG7487R1002
TICKER
RGC
MIC
XNAS
REUTERS
RGC.OQ
BLOOMBERG
RGC US
Sat, 25.04.2026       Regencell Bioscience
KYG7487R1002

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercializatio...
Read more
Regencell Bioscience
Technical Analysis Termsheets Terminal
Permalink
Thu, 20.11.2025       Regencell Bioscience
KYG7487R1002

NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Regencell Bioscience
Technical Analysis Termsheets Terminal
Permalink